Immediate Management of Bradycardia
For a patient with symptomatic bradycardia causing hemodynamic instability (altered mental status, chest pain, heart failure, hypotension, or shock), immediately administer atropine 0.5 mg IV as first-line therapy, and prepare for transcutaneous pacing if atropine fails. 1
Initial Assessment and Stabilization
The first critical step is determining whether the bradycardia is causing the patient's symptoms. **Bradycardia requiring treatment typically has a heart rate <50 bpm** 2. However, focus on clinical status rather than an arbitrary number—some patients tolerate rates >50 bpm poorly while athletes may be asymptomatic at lower rates.
Immediate Actions (Do Not Delay):
- Assess and support airway/breathing - Hypoxemia commonly causes bradycardia 2
- Provide oxygen if hypoxemic 2
- Attach cardiac monitor and obtain vital signs 2
- Establish IV access 2
- Obtain 12-lead ECG (but don't delay treatment) 2
- Identify and treat reversible causes 3
Key Reversible Causes to Consider:
- Hyperkalemia (check immediately if suspected—BRASH syndrome) 4
- Acute MI/ischemia 3
- Medications (beta-blockers, calcium channel blockers, digoxin) 3, 4
- Hypothyroidism, hypothermia 3
- Hypoxemia, increased ICP 5
Pharmacologic Management Algorithm
Step 1: Atropine (First-Line)
Dose: 0.5 mg IV every 3-5 minutes, maximum total 3 mg 2
- Class IIa recommendation for symptomatic bradycardia 1
- Works by blocking parasympathetic (vagal) effects on the heart 3
- Critical caveat: Do NOT use doses <0.5 mg—paradoxically may worsen bradycardia 2
- Use cautiously in acute MI (may worsen ischemia) 2
- Contraindicated in heart transplant patients without autonomic reinnervation (will be ineffective) 3
Step 2: If Atropine Fails
Initiate transcutaneous pacing (TCP) AND/OR chronotropic infusions 1
Transcutaneous Pacing:
- Class IIa recommendation for unstable patients unresponsive to atropine 1
- Consider immediate pacing for high-degree AV block when IV access unavailable 1
- Provide sedation/analgesia as TCP is painful in conscious patients
Chronotropic Infusions (Class IIb):
Dopamine: 5-20 mcg/kg/min 1, 3
- Particularly useful if hypotension present
- Mixed alpha/beta effects provide both chronotropy and blood pressure support
Epinephrine: 2-10 mcg/min 1, 3
- Alternative beta-agonist with rate-accelerating effects
Isoproterenol: May be considered but use cautiously 3
- Pure beta-agonist (chronotropic/inotropic)
- Avoid if coronary ischemia suspected (increases myocardial oxygen demand)
Step 3: Definitive Management
If bradycardia persists despite medications and TCP, prepare for transvenous pacing 1
- Class IIa recommendation for refractory cases 1
- Provides more reliable pacing than transcutaneous approach
- Bridge to permanent pacemaker if indicated 6, 3
Special Situations
BRASH Syndrome (Critical Pitfall)
Bradycardia + Renal failure + AV nodal blockade + Shock + Hyperkalemia 4
- Standard ACLS bradycardia treatment (atropine) is INEFFECTIVE 4
- Must treat hyperkalemia and remove offending medications
- Calcium, insulin/glucose, dialysis may be needed
- Early recognition prevents multiorgan failure 4
High-Degree AV Block
Mobitz II or third-degree AV block with acute MI 2:
- High risk for progression even if minimally symptomatic
- Consider prophylactic temporary pacing
- Atropine may be ineffective (block below AV node) 2
Asymptomatic or Minimally Symptomatic Patients
Do NOT treat bradycardia solely based on heart rate number 2
- Observe and evaluate for reversible causes 3
- Exception: High-risk rhythms (Mobitz II, complete heart block in MI setting) may warrant intervention 2
Common Pitfalls to Avoid
- Using atropine doses <0.5 mg (paradoxical worsening) 2
- Giving atropine to heart transplant patients (ineffective) 3
- Delaying pacing while giving multiple atropine doses in unstable patients 2
- Missing BRASH syndrome and treating with standard ACLS alone 4
- Using isoproterenol in acute coronary syndrome (worsens ischemia) 3
- Treating asymptomatic bradycardia aggressively without identifying cause 2
- Failing to identify and correct hyperkalemia before other interventions 4, 5
Summary Treatment Pathway
Symptomatic/Unstable Bradycardia:
- Atropine 0.5 mg IV (repeat q3-5min, max 3 mg)
- If fails → TCP + chronotropic infusion (dopamine/epinephrine)
- If refractory → Transvenous pacing
- Throughout: Identify and treat reversible causes
Asymptomatic/Stable Bradycardia:
- Observe, evaluate for reversible causes
- Consider intervention only if high-risk rhythm or likely to progress